Helios Brands, Inc. · in-house marketing compliance
Source: AstaRx — landing page draft
“AstaRx is the only treatment that works. Start living again.”
Prescription advertising must present a true statement of side effects, contraindications, and effectiveness — fair balance under 21 CFR § 202.1. Benefit-only copy that skips the boxed warning is also misbranding under 21 U.S.C. § 352(n).
Add major risks with comparable prominence, or run a reminder ad that actually meets the reminder conditions. Do not ship this unit.
A draft for the officer. RuleCites does not clear copy.